Skip to main content
. 2022 Jul 3;24:100485. doi: 10.1016/j.bbih.2022.100485

Table 3.

Incidence of reported symptoms at baseline and at 2 months.

Symptoms Baseline n(%) 2 month follow up n(%) P value (2 tailed <0.05)
Total 36 36
Fatigue 33(91.7) 27(75) .085
Fevers 6(16.7) 2(5.6) .185
Sore throat 13(36.1) 8(22.2) .136
Anosmia/dysgeusia 16(44.4) 11(30.6) .171
Hair loss 11(30.6) 9(25) .65
Tinnitus 17(47.2) 12(33.3) .2
Chest pain/tightness 20(55.6) 12(33.3) .047
Palpitations 22(61.1) 16(44.4) .132
Cough 19(37.3) 5(13.9) .016
Shortness of breath 25(69.4) 19(52.8) .09
Headache 27(75) 24(63.9) .314
Dizziness 17(47.2) 14(38.9) .618
Brain fog 27(75) 20(55.6) .072
Sleep disturbance 26(72.2) 16(44.4) .058
Dysthesia 20(55.6) 13(36.1) .056
Abdominal discomfort/bloating 17(47.2) 14(38.9) .449
Nausea/Vomiting 12(33.3) 6(16.7) .083
Diarrhoea 14(38.9) 9(25) .166
Joint pain 26(72.2) 13(36.1) .008
Myalgia 20(55.6) 14(38.9) .163
Low mood 28(77.8) 17(47.2) .003
Anxiety 20(55.6) 16(44.4) .337
Personality change 9(25) 0(0) .001